- decreased exploration in new environment / IMPC
- limb grasping / IMPC
- increased circulating triglyceride level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased circulating amylase level / IMPC
- increased red blood cell distribution width / IMPC
- preweaning lethality, incomplete penetrance / IMPC
C57BL/6N-Elovl6tm1b(EUCOMM)Hmgu/H
| Status | Only small colony available |
| EMMA ID | EM:16362 |
| Citation information | RRID:IMSR_EM:16362 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | C57BL/6N-Elovl6tm1b(EUCOMM)Hmgu/H |
| Alternative name | HEPD0729_3_F04 |
| Strain type | Targeted Mutant Strains |
| Allele/Transgene symbol | Elovl6tm1b(EUCOMM)Hmgu |
| Gene/Transgene symbol | Elovl6 |
| Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
| Provider | Mary Lyon Centre at MRC Harwell |
| Provider affiliation | Mary Lyon Centre at MRC Harwell |
| Genetic information | This mouse line originates from EUCOMM ES clone HEPD0729_3_F04. For further details on the construction of this clone see the page at the IMPC portal. The critical exon(s) were flanked by loxP sites, and subsequent cre expression excised this critical sequence resulting in a knockout reporter allele. Click here for more information on EUCOMM final vectors. |
| Phenotypic information | Potential phenotyping data in the IMPC portal |
| References | None available |
Information from EMMA
| Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased circulating alkaline phosphatase level / IMPC
- limb grasping / IMPC
- increased circulating triglyceride level / IMPC
- increased red blood cell distribution width / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- increased circulating amylase level / IMPC
- decreased exploration in new environment / IMPC
MGI phenotypes (gene matching)
- abnormal liver morphology / MGI
- abnormal lipid homeostasis / MGI
- hepatic steatosis / MGI
- decreased circulating insulin level / MGI
- increased insulin sensitivity / MGI
- enhanced coordination / MGI
- increased lean body mass / MGI
- decreased circulating cholesterol level / MGI
- abnormal pancreatic islet morphology / MGI
- abnormal fatty acid level / MGI
- improved glucose tolerance / MGI
- growth/size/body region phenotype / MGI
- decreased circulating leptin level / MGI
- abnormal hepatocyte physiology / MGI
- embryonic lethality, incomplete penetrance / MGI
- decreased fatty acid oxidation / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).
